Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells

Journal of Leukocyte Biology

Volumn 83, Issue 1, 2008, Pages 56-63

  Wagner, Claudia S ^a   Walther Jallow, Lilian ^a   Buentke, Eva ^a   Ljunggren, Hans Gustaf ^a   Achour, Adnane ^a   Chambers, Benedict J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell surface molecules; Cell trafficking; Host pathogen interaction; Immune modulation; MHC class I homologue

Indexed keywords

CD40 ANTIGEN; CD83 ANTIGEN; HYBRID PROTEIN; PROTEIN UL18; UNCLASSIFIED DRUG;

ARTICLE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; LEUKOCYTE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD; CAPSID PROTEINS; CD40 LIGAND; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHENOTYPE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

HUMAN HERPESVIRUS 5;

EID: 38149011403     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0307181     Document Type: Article

References (61)

1. West, M. A., Wallin, R. P., Matthews, S. P., Svensson, H. G., Zaru, R., Ljunggren, H. G., Prescott, A. R., Watts, C. (2004) Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305, 1153-1157.
2. Munz, C., Steinman, R. M., Fujii, S. (2005) Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202, 203-207.
3. Sissons, J. G., Carmichael, A. J., McKinney, N., Sinclair, J. H., Wills, M. R. (2002) Human cytomegalovirus and immunopathology. Springer Semin. Immunopathol. 24, 169-185.
4. Mocarski Jr., E. S. (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10, 332-339.
5. Basta, S., Bennink, J. R. (2003) A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. Viral Immunol. 16, 231-242.
6. Rajagopalan, S., Long, E. O. (2005) Viral evasion of NK-cell activation. Trends Immunol. 26, 403-405.
7. Bosnjak, L., Jones, C. A., Abendroth, A., Cunningham, A. L. (2005) Dendritic cell biology in herpesvirus infections. Viral Immunol. 18, 419-433.
8. Yewdell, J. W., Hill, A. B. (2002) Viral interference with antigen presentation. Nat. Immunol. 3, 1019-1025.
9. Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., Schonrich, G. (2001) Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997-1009.
10. Moutaftsi, M., Mehl, A. M., Borysiewicz, L. K., Tabi, Z. (2002) Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99, 2913-2921.
11. Beck, K., Meyer-Konig, U., Weidmann, M., Nern, C., Hufert, F. T. (2003) Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur. J. Immunol. 33, 1528-1538.
12. Grigoleit, U., Riegler, S., Einsele, H., Laib Sampaio, K., Jahn, G., Hebart, H., Brossart, P., Frank, F., Sinzger, C. (2002) Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br. J. Haematol. 119, 189-198.
13. Hertel, L., Lacaille, V. G., Strobl, H., Mellins, E. D., Mocarski, E. S. (2003) Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77, 7563-7574.
14. Frascaroli, G., Varani, S., Mastroianni, A., Britton, S., Gibellini, D., Rossini, G., Landini, M. P., Soderberg-Naucler, C. (2006) Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. J. Leukoc. Biol. 79, 932-940.
15. Senechal, B., Boruchov, A. M., Reagan, J. L., Hart, D. N., Young, J. W. (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103, 4207-4215.
16. Kvale, E. O., Dalgaard, J., Lund-Johansen, F., Rollag, H., Farkas, L., Midtvedt, K., Jahnsen, F. L., Brinchmann, J. E., Olweus, J. (2006) CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 107, 2022-2029.
17. Reyburn, H. T., Mandelboim, O., Vales-Gomez, M., Davis, D. M., Pazmany, L., Strominger, J. L. (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386, 514-517.
18. Kim, J. S., Choi, S. E., Yun, I. H., Kim, J. Y., Ahn, C., Kim, S. J., Ha, J., Hwang, E. S., Cha, C. Y., Miyagawa, S., Park, C. G. (2004) Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. Biochem. Biophys. Res. Commun. 315, 144-150.
19. Leong, C. C., Chapman, T. L., Bjorkman, P. J., Formankova, D., Mocarski, E. S., Phillips, J. H., Lanier, L. L. (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187, 1681-1687.
20. Odeberg, J., Cerboni, C., Browne, H., Karre, K., Moller, E., Carbone, E., Soderberg-Naucler, C. (2002) Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand. J. Immunol. 55, 149-161.
21. Prod'homme, V., Griffin, C., Aicheler, R. J., Wang, E. C., McSharry, B. P., Rickards, C. R., Stanton, R. J., Borysiewicz, L. K., Lopez-Botet, M., Wilkinson, G. W., Tomasec, P. (2007) The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J. Immunol. 178, 4473-4481.
22. Saverino, D., Ghiotto, F., Merlo, A., Bruno, S., Battini, L., Occhino, M., Maffei, M., Tenca, C., Pileri, S., Baldi, L., Fabbi, M., Bachi, A., De Santanna, A., Grossi, C. E., Ciccone, E. (2004) Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172, 5629-5637.
23. Wagner, C. S., Riise, G. C., Bergstrom, T., Karre, K., Carbone, E., Berg, L. (2007) Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J. Immunol. 178, 3536-3543.
24. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., Hsu, M. L. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282.
25. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M., Lopez-Botet, M. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818.
26. Sayos, J., Martinez-Barriocanal, A., Kitzig, F., Bellon, T., Lopez-Botet, M. (2004) Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem. Biophys. Res. Commun. 324, 640-647.
27. Colonna, M., Nakajima, H., Navarro, F., Lopez-Botet, M. (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66, 375-381.
28. Chapman, T. L., Heikeman, A. P., Bjorkman, P. J. (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11, 603-613.
29. Cosman, D., Fanger, N., Borges, L. (1999) Human cytomegalovirus, MHC class I and inhibitory signaling receptors: more questions than answers. Immunol. Rev. 168, 177-185.
30. Lodoen, M. B., Lanier, L. L. (2005) Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3, 59-69.
31. Garrone, P., Neidhardt, E. M., Garcia, E., Galibert, L., van Kooten, C., Banchereau, J. (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182, 1265-1273.
32. Fanslow, W. C., Anderson, D. M., Grabstein, K. H., Clark, E. A., Cosman, D., Armitage, R. J. (1992) Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149, 655-660.
33. Wagner, C. S., Rolle, A., Cosman, D., Ljunggren, H. G., Berndt, K. D., Achour, A. (2007) Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1. J. Mol. Biol. 373, 695-705.
34. Michaelsson, J., Achour, A., Rolle, A., Karre, K. (2001) MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the β 2-microglobulin subunit. J. Immunol. 166, 7327-7334.
35. de Jager, W., te Velthuis, H., Prakken, B. J., Kuis, W., Rijkers, G. T. (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10, 133-139.
36. Tenca, C., Merlo, A., Merck, E., Bates, E. E., Saverino, D., Simone, R., Zarcone, D., Trinchieri, G., Grossi, C. E., Ciccone, E. (2005) CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J. Immunol. 174, 6757-6763.
37. Chang, T. L., Gordon, C. J., Roscic-Mrkic, B., Power, C., Proudfoot, A. E., Moore, J. P., Trkola, A. (2002) Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity. J. Virol. 76, 2245-2254.
38. Sato, K., Kawasaki, H., Nagayama, H., Enomoto, M., Morimoto, C., Tadokoro, K., Juji, T., Takahashi, T. A. (2001) Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages. Int. Immunol. 13, 167-179.
39. Servet-Delprat, C., Vidalain, P. O., Bausinger, H., Manie, S., Le Deist, F., Azocar, O., Hanau, D., Fischer, A., Rabourdin-Combe, C. (2000) Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol. 164, 1753-1760.
40. Vidalain, P. O., Azocar, O., Servet-Delprat, C., Rabourdin-Combe, C., Gerlier, D., Manie, S. (2000) CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 19, 3304-3313.
41. Bellon, T., Kitzig, F., Sayos, J., Lopez-Botet, M. (2002) Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J. Immunol. 168, 3351-3359.
42. Ince, M. N., Harnisch, B., Xu, Z., Lee, S. K., Lange, C., Moretta, L., Lederman, M., Lieberman, J. (2004) Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 112, 531-542.
43. Saverino, D., Fabbi, M., Ghiotto, F., Merlo, A., Bruno, S., Zarcone, D., Tenca, C., Tiso, M., Santoro, G., Anastasi, G., Cosman, D., Grossi, C. E., Ciccone, E. (2000) The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165, 3742-3755.
44. Saverino, D., Merlo, A., Bruno, S., Pistoia, V., Grossi, C. E., Ciccone, E. (2002) Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J. Immunol. 168, 207-215.
45. Zhou, L. J., Tedder, T. F. (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154, 3821-3835.
46. Lechmann, M., Krooshoop, D. J., Dudziak, D., Kremmer, E., Kuhnt, C., Figdor, C. G., Schuler, G., Steinkasserer, A. (2001) The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194, 1813-1821.
47. Sozzani, S., Allavena, P., Vecchi, A., Mantovani, A. (1999) The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66, 1-9.
48. Bacon, K. B., Szabo, M. C., Yssel, H., Bolen, J. B., Schall, T. J. (1996) RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J. Exp. Med. 184, 873-882.
49. Bacon, K. B., Premack, B. A., Gardner, P., Schall, T. J. (1995) Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269, 1727-1730.
50. Dikic, I., Dikic, I., Schlessinger, J. (1998) Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. J. Biol. Chem. 273, 14301-14308.
51. Inngjerdingen, M., Rolstad, B., Ryan, J. C. (2003) Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. J. Immunol. 171, 2889-2895.
52. Varani, S., Frascaroli, G., Homman-Loudiyi, M., Feld, S., Landini, M. P., Soderberg-Naucler, C. (2005) Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol. 77, 219-228.
53. Moutaftsi, M., Brennan, P., Spector, S. A., Tabi, Z. (2004) Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J. Virol. 78, 3046-3054.
54. D'Amico, G., Frascaroli, G., Bianchi, G., Transidico, P., Doni, A., Vecchi, A., Sozzani, S., Allavena, P., Mantovani, A. (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1, 387-391.
55. Khader, S. A., Partida-Sanchez, S., Bell, G., Jelley-Gibbs, D. M., Swain, S., Pearl, J. E., Ghilardi, N., Desauvage, F. J., Lund, F. E., Cooper, A. M. (2006) Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203, 1805-1815.
56. Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G., Sinclair, J. H. (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. USA 102, 4140-4145.
57. Gallucci, S., Matzinger, P. (2001) Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
58. Park, B., Oh, H., Lee, S., Song, Y., Shin, J., Sung, Y. C., Hwang, S. Y., Ahn, K. (2002) The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. J. Immunol. 168, 3464-3469.
59. Griffin, C., Wang, E. C., McSharry, B. P., Rickards, C., Browne, H., Wilkinson, G. W., Tomasec, P. (2005) Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J. Gen. Virol. 86, 2999-3008.
60. Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., Khanna, R. (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77, 5226-5240.
61. He, H., Rinaldo Jr., C. R., Morel, P. A. (1995) T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development. J. Gen. Virol. 76, 1603-1610.